Spatial biology is transforming how we study health and disease by answering a deceptively simple question: where are cells, and how do they interact in their natural environment? While traditional molecular techniques have provided powerful insights into gene and protein expression, they often lose the crucial context of tissue architecture. Spatial biology brings that context back.
At its core, spatial biology is the study of the spatial distribution and interactions of biomarkers and cells within tissues. In pathology, this means examining how different cell types – immune cells, stromal cells, tumour cells, vessels etc – are arranged within a tissue section and how they communicate with one another. This spatial context is essential, as cells do not exist in isolation; their behaviour and influence are integrated with their neighbours and microenvironment.
In practical terms, spatial biology in pathology relies on advanced multiplex imaging technologies. These techniques allow for the simultaneous detection of multiple biomarkers within a single tissue section, up to whole-transcriptome when required. Platforms such as multiplex immunofluorescence and in situ imaging systems enable researchers and clinicians to visualise the interactions of complex systems and track biomarker and therapeutic distribution while preserving the spatial relationships between cells.
This spatial resolution opens entirely new dimensions of insight. For example, in oncology, it becomes possible to map the immune landscape of a tumour: identifying not just which immune cells are present, but whether they are actively infiltrating the tumour, excluded from it, or forming organised structures nearby and exposes molecular mechanisms behind intra-tumoral heterogeneity. These spatial networks and niches can have direct implications for prognosis and response to therapies.
Beyond cancer, spatial biology is being applied across a wide range of diseases, from chronic inflammation to neurodegeneration. By analysing how cells are organised and interact within tissue, researchers can uncover mechanisms that would remain hidden in bulk or single-cell analyses alone.
Importantly, spatial biology is not just about generating more data – it is about context. By combining multiplexed molecular information with precise localisation, it provides a more holistic view of biology in situ.
As technologies continue to evolve, spatial biology is becoming increasingly accessible and scalable, positioning it as a key tool in both research and clinical settings. The trade-offs between sample throughput, target plexity, analyte type, resolution and sensitivity are rapidly being resolved. For pathology in particular, it represents a natural progression towards more quantitative, data-rich, and insightful analysis of tissue.
In short, spatial biology bridges the gap between molecular detail and tissue context—offering a clearer picture of how biology truly operates within the human body – and the mechanism of responses to both disease and therapy.
